News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

Spritam (levetiracetam) for the Treatment of Epilepsy

Spritam (levetiracetam) is an adjunctive therapy indicated for the treatment of seizures in patients with epilepsy, the fourth most...

Trobalt / Potiga – Treatment for Partial-Onset Seizure

Trobalt (ezogabine / retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged more than 18 years old.

Sivextro for Treatment of Acute Bacterial Skin and Skin Structure Infections

Sivextro (tedizolid phosphate) is an oxazolidinone class antibacterial drug indicated for treatment of adult patients infected with acute...

Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Paediatric Patients

Dysport (abobotulinumtoxinA) is an injectable formulation developed by Ipsen Biopharmaceuticals for the treatment of lower limb...

Latest Products & Services

Malvern Instruments
Zetasizer AT for DLS
Malvern's Zetasizer AT brings the industry leading Dynamic Light Scattering (DLS) technology of the Zetasizer Nano to the process development and manufacturing arena, enabling real...
See all products